» Articles » PMID: 24212632

Treatment Resistance Mechanisms of Malignant Glioma Tumor Stem Cells

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2013 Nov 12
PMID 24212632
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Malignant gliomas are highly lethal because of their resistance to conventional treatments. Recent evidence suggests that a minor subpopulation of cells with stem cell properties reside within these tumors. These tumor stem cells are more resistant to radiation and chemotherapies than their counterpart differentiated tumor cells and may underlie the persistence and recurrence of tumors following treatment. The various mechanisms by which tumor stem cells avoid or repair the damaging effects of cancer therapies are discussed.

Citing Articles

HBx Facilitates Drug Resistance in Hepatocellular Carcinoma via CD133-regulated Self-renewal of Liver Cancer Stem Cells.

Jin X, Dong H, Wang J, Ou G, Lai X, Tian X J Clin Transl Hepatol. 2025; 13(1):15-24.

PMID: 39801781 PMC: 11712087. DOI: 10.14218/JCTH.2024.00259.


A Brain-Penetrating Hsp90 Inhibitor NXD30001 Inhibits Glioblastoma as a Monotherapy or in Combination With Radiation.

Chen H, Gong Y, Ma Y, Thompson R, Wang J, Cheng Z Front Pharmacol. 2020; 11:974.

PMID: 32695001 PMC: 7338553. DOI: 10.3389/fphar.2020.00974.


Analysis of microarray data for identification of key microRNA signatures in glioblastoma multiforme.

Shaji S, Sunilkumar D, Mahalakshmi N, Kumar G, Nair B Oncol Lett. 2019; 18(2):1938-1948.

PMID: 31423264 PMC: 6614686. DOI: 10.3892/ol.2019.10521.


Glioblastoma Chemoresistance: The Double Play by Microenvironment and Blood-Brain Barrier.

Da Ros M, De Gregorio V, Iorio A, Giunti L, Guidi M, de Martino M Int J Mol Sci. 2018; 19(10).

PMID: 30248992 PMC: 6213072. DOI: 10.3390/ijms19102879.


Targeted nanoparticle delivery of therapeutic antisense microRNAs presensitizes glioblastoma cells to lower effective doses of temozolomide and in a mouse model.

Malhotra M, Sekar T, Ananta J, Devulapally R, Afjei R, Babikir H Oncotarget. 2018; 9(30):21478-21494.

PMID: 29765554 PMC: 5940368. DOI: 10.18632/oncotarget.25135.


References
1.
Kang M, Hur B, Ko M, Kim C, Cha S, Kang S . Potential identity of multi-potential cancer stem-like subpopulation after radiation of cultured brain glioma. BMC Neurosci. 2008; 9:15. PMC: 2266936. DOI: 10.1186/1471-2202-9-15. View

2.
Sonneveld P, Suciu S, Weijermans P, Beksac M, Neuwirtova R, Solbu G . Cyclosporin A combined with vincristine, doxorubicin and dexamethasone (VAD) compared with VAD alone in patients with advanced refractory multiple myeloma: an EORTC-HOVON randomized phase III study (06914). Br J Haematol. 2002; 115(4):895-902. DOI: 10.1046/j.1365-2141.2001.03171.x. View

3.
Abdouh M, Facchino S, Chatoo W, Balasingam V, Ferreira J, Bernier G . BMI1 sustains human glioblastoma multiforme stem cell renewal. J Neurosci. 2009; 29(28):8884-96. PMC: 6665439. DOI: 10.1523/JNEUROSCI.0968-09.2009. View

4.
Phi J, Park S, Kim S, Paek S, Kim J, Lee Y . Sox2 expression in brain tumors: a reflection of the neuroglial differentiation pathway. Am J Surg Pathol. 2007; 32(1):103-12. DOI: 10.1097/PAS.0b013e31812f6ba6. View

5.
Stupp R, Mason W, van den Bent M, Weller M, Fisher B, Taphoorn M . Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005; 352(10):987-96. DOI: 10.1056/NEJMoa043330. View